Detalhe da pesquisa
1.
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
Antimicrob Agents Chemother
; 66(6): e0013222, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607978
2.
First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment.
Antimicrob Agents Chemother
; 63(8)2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31182528
3.
Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor.
EBioMedicine
; 8: 291-301, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27428438
4.
Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination.
Clin Vaccine Immunol
; 21(4): 594-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24501340